formaldehyde has been researched along with Escherichia coli Infections in 17 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tobias, J | 2 |
| Svennerholm, AM | 2 |
| Carlin, NI | 1 |
| Lebens, M | 2 |
| Holmgren, J | 1 |
| Miqdady, MS | 1 |
| Jiang, ZD | 1 |
| Nataro, JP | 1 |
| DuPont, HL | 1 |
| SACHSE, HH | 1 |
| MAURER, T | 1 |
| SCHMIDT, EF | 1 |
| OCKLITZ, HW | 1 |
| Kikuchi, T | 1 |
| Kobayashi, T | 1 |
| Gomi, K | 1 |
| Suzuki, T | 1 |
| Tokue, Y | 1 |
| Watanabe, A | 1 |
| Nukiwa, T | 1 |
| Liao, CW | 1 |
| Lin, SH | 1 |
| Lin, PY | 1 |
| Chiou, HY | 1 |
| Chang, WF | 1 |
| Weng, CN | 1 |
| Russo, TA | 1 |
| Beanan, JM | 1 |
| Olson, R | 1 |
| Genagon, SA | 1 |
| MacDonald, U | 1 |
| Cope, JJ | 1 |
| Davidson, BA | 1 |
| Johnston, B | 1 |
| Johnson, JR | 1 |
| Bölin, I | 1 |
| Wiklund, G | 1 |
| Larsson, P | 1 |
| Kaijser, B | 1 |
| Baltzer, IM | 1 |
| Olling, S | 1 |
| Nahata, MC | 1 |
| Cummins, BA | 1 |
| McLeod, DC | 1 |
| Butler, R | 1 |
| Paton, JC | 1 |
| Rogers, TJ | 1 |
| Morona, R | 1 |
| Paton, AW | 1 |
| Ward, GE | 1 |
| Bigland, CH | 1 |
| Hill, WK | 1 |
| Akkermans, JP | 1 |
| MacLeod, DL | 1 |
| Gyles, CL | 1 |
| Rutter, JM | 1 |
| Anderson, JC | 1 |
| Radford, NJ | 1 |
| Chick, S | 1 |
| Ling, R | 1 |
| Coles, GA | 1 |
| Asscher, AW | 1 |
| Kasanen, A | 1 |
| Mustakallio, E | 1 |
| Koskinen, EH | 1 |
| Soini, V | 1 |
17 other studies available for formaldehyde and Escherichia coli Infections
| Article | Year |
|---|---|
Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Topics: Administration, Oral; Animals; Antibodies, Bacterial; Antibody Formation; Antigens, Bacterial; Esche | 2011 |
Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells.
Topics: Bacterial Adhesion; Cell Line; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Fixa | 2002 |
[CONSIDERATION OF A CHEMOTHERMAL DISINFECTIVE WASHING METHODS COMPARED WITH THE CHEMICAL LAUNDRY DISINFECTION ON THE WARD FOR THE CONTROL OF HOSPITAL INFECTION].
Topics: Bedding and Linens; Cross Infection; Disinfection; Escherichia coli Infections; Formaldehyde; Humans | 1964 |
[Disinfection in an infant clinic with a special reference to infection with coli dyspepsiae].
Topics: Ambulatory Care Facilities; Antisepsis; Asepsis; Disinfection; Dyspepsia; Escherichia coli; Escheric | 1955 |
Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses.
Topics: Animals; Antibodies, Bacterial; Cell Division; Cell Membrane; Cytokines; Dendritic Cells; Escherichi | 2004 |
Orally administrable enterotoxigenic Escherichia coli vaccine encapsulated by ethylcellulose powder dispersion.
Topics: Administration, Oral; Animals; Antigens, Bacterial; Cellulose; Chemistry, Pharmaceutical; Enterotoxi | 2004 |
A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.
Topics: Administration, Intranasal; Animals; Antibodies, Bacterial; Bacterial Capsules; Blood; Escherichia c | 2007 |
Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Topics: Administration, Oral; Animals; Antibodies, Bacterial; Bacterial Vaccines; Enterotoxigenic Escherichi | 2008 |
Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
Topics: Animals; Bacterial Vaccines; Escherichia coli Infections; Female; Formaldehyde; Immune Sera; Immuniz | 1980 |
Predictability of methenamine efficacy based on type of urinary pathogen and pH.
Topics: Aged; Ascorbic Acid; Bacteriuria; Escherichia coli Infections; Female; Formaldehyde; Humans; Hydroge | 1981 |
Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli.
Topics: Administration, Oral; Animals; Escherichia coli; Escherichia coli Infections; Escherichia coli Vacci | 2001 |
Use of a formalin-treated, live Escherichia coli vaccine in the prevention of neonatal enteric colibacillosis in swine.
Topics: Animals; Animals, Newborn; Bacterial Vaccines; Diarrhea; Escherichia coli Infections; Formaldehyde; | 1976 |
[E. coli enterotoxicosis in unweaned piglets. III. Preparation and use of vaccines in enterotoxaemia due to E. coli in newborn piglets in the Netherlands].
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Animals, Newborn; Antigens, Bacterial; Bacteria | 1976 |
Immunization of pigs with a purified Shiga-like toxin II variant toxoid.
Topics: Animals; Antibodies, Bacterial; Bacterial Toxins; Enterotoxins; Escherichia coli; Escherichia coli I | 1991 |
Experimental neonatal diarrhoea caused by an enteropathogenic strain of Escherichia coli in piglets: a study of the disease and the effect of vaccinating the dam.
Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Antibodies; Bacterial Vaccines; Colostrum; Comple | 1972 |
The effect of active immunisation on ascending pyelonephritis in the rat.
Topics: Animals; Antibodies, Bacterial; Bacterial Vaccines; Escherichia coli; Escherichia coli Infections; F | 1974 |
Methenamine hippurate in the treatment of urinary tract infections.
Topics: Acute Disease; Adult; Creatinine; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Inf | 1974 |